American Liver Foundation

03/10/2026

Today we’re highlighting FLAVORS, our national culinary event, and the incredible talent of James Porter, owner of TERRA Farm and Manor.

Chef Porter shared:
“Flavors is such a great opportunity to support a cause that is near and dear to my heart. I have witnessed the gift of a liver transplant and the impact it has on a family.“

We are so grateful to Chef Porter and can’t wait for him to serve at FLAVORS on April 15th at the Arizona Biltmore in Phoenix. Learn more about this unique event: https://alf.social/Flavors

03/09/2026

Happy Marathon Monday! Today we are highlighting Team ALF runner Lauren Ordower! Lauren will be running the 2026 United Airlines NYC Half Marathon on March 15th, 2026!

Lauren is running in tribute to her father, whose courage was extraordinary and who was profoundly committed to his family and ALF. Lauren said, “ALF has become deeply meaningful to our family. Each year, we donate in my dad’s memory, honoring an unbelievably brave man and an extraordinary father.”

This will be Lauren’s second time running with Team ALF!

Read more about Lauren and support her here:
https://alf.social/nychalford

03/09/2026

HRS-AKI (hepatorenal syndrome–acute kidney injury) is a serious complication of advanced liver disease, especially cirrhosis, marked by a rapid decline in kidney function. It can quickly progress to life-threatening kidney failure and requires urgent medical attention.

Learn more about Hepatorenal Syndrome with Acute Kidney Injury (HRS-AKI) with our print-friendly infographic: https://alf.social/HRSAKIp2

03/09/2026

On July 16, 2025, the American Liver Foundation and the National Kidney Foundation convened the 2025 National Dialogue on Hepatorenal Syndrome with Acute Kidney Injury (HRS-AKI) sponsored by Mallinckrodt Pharmaceuticals (now Keenova). Please find the meeting report attached. https://alf.social/HRSAKIp

03/08/2026

This Women’s History Month, we’re proud to highlight women leading the way in liver health.

Today we feature Tamar H. Taddei, MD, FAASLD, Chief of Digestive Diseases at VA Connecticut Health Care System and Professor at Yale School of Medicine.

Inspired by witnessing her institution’s first liver transplant as a medical student, Dr. Taddei has dedicated her career to caring for Veterans facing a high burden of liver disease. She also honors her mother’s memory each day through her commitment to exceptional patient care.

Her involvement with American Liver Foundation, from early Liver Walk participation to ongoing engagement, reflects her belief in the power of community to educate, advocate, and ease suffering.

Fun fact: Her undergraduate degree was in diplomacy — skills she still uses daily.

Thank you, Dr. Taddei, for your leadership and unwavering dedication.

03/07/2026

The Center for Information and Study on Clinical Research Participation (CISCRP), together with a pharmaceutical company, is planning a virtual focus group with adults diagnosed with metastatic hepatocellular carcinoma (mHCC) and/or their care partners to discuss their experiences, share general thoughts on clinical research, and provide feedback on a proposed clinical study evaluating a new treatment for mHCC.

The goal of the focus group is not to recruit for a clinical trial, but rather to learn from patients and care partners how to best create a clinical trial that addresses the unique needs of individuals with this condition.
The virtual focus group would take place in March 2026, with the exact date and time to be determined based on participant availability. The focus group will be conducted virtually using an online platform (Zoom) as a single 2-hour meeting.

As a thank you for your time, CISCRP will provide an honorarium for those who are eligible and participate.

If you are interested in participating in this opportunity or have any additional questions, please visit: https://alf.social/CISCRPmHCC to fill out your form and we’ll get back to you shortly.

03/07/2026

Here’s a Feel Good Friday story that highlights just how incredible the liver and the people who donate truly are.

When 100-year-old World War II veteran Dale Steele of Nebraska passed away earlier this year, his life of service didn’t end. His liver was donated and successfully transplanted the very next day, making him the oldest organ donor in U.S. history.

It’s a powerful reminder that there isn’t a simple age limit for organ donation every donor is evaluated individually. And it’s also proof of something we know well: the liver is an amazing organ capable of giving someone a second chance at life.

Read more:

A 100-year-old veteran from Pierce, Nebraska became the nation’s oldest organ donor when he died in February. Live On Nebraska, the state’s organ procurement organization, says Dan Steele was raised…

03/06/2026

In 1980, ALF established the Research Awards Program, recognizing that scientific breakthroughs begin with bold ideas and early-career investigators. Since then, the program has invested nearly $30 million in researchers whose discoveries continue to shape the future of liver medicine.

Celebrating 50 years of impact — leading the next 50 years forward.

03/05/2026

🗽 Big city. Big crowds. Big purpose.

Run the world’s largest marathon with Team ALF at the 2026 TCS New York City Marathon. Join a supportive team, feel the unmatched NYC energy, and help support the 100 million Americans affected by liver disease.

Applications are open, apply today! https://alf.social/tcsnyc26

03/04/2026

Big news for living organ donors!

The Senate HELP Committee has passed the Living Donor Protection Act (S.1552) out of committee — an important step toward protecting the people who give the gift of life.

As our CEO, Lorraine Stiehl, shared, this bill is essential to protecting living donors and offering hope to patients and families waiting for a lifesaving transplant.

Now we need Congress to finish the job.

Urge your lawmakers to vote YES on S.1552 and protect living donors and the patients who depend on them.

Take action now: https://liver.news/vvldpata

03/02/2026

March is Women’s History Month, and all month we’re celebrating women making a difference in liver health. 💚💙

Today we’re featuring Renu Dhanasekaran, MD, PhD, Assistant Professor at Stanford University.

Drawn to complex clinical challenges, Dr. Dhanasekaran chose hepatology for its multidisciplinary care and transformative therapies — from antivirals to liver transplantation. Seeing patients with advanced liver tumors return years later, cancer-free, continues to fuel her clinical and research work.

Through her involvement with American Liver Foundation as both a peer reviewer and research grant recipient, she has helped advance rigorous, patient-centered liver disease research nationwide.

Fun fact: She speaks six languages and was once a national finalist in medical Jeopardy!

Thank you, Dr. Dhanasekaran, for strengthening the liver community through care, research, and collaboration.

02/28/2026

Today is Rare Disease Day, and we’re turning our focus on Lysomal acid lipase deficiency (LALD). LALD is a rare, genetic condition that causes individuals to have an uncontrolled buildup of fatty material in their cells. Most people will have symptoms by the age of 5. There are therapies to treat the disease, and supportive treatments available. Learn more: https://alf.social/LALD